Guardion Health: Rises after eye drug shows promise in study

Guardion Health Sciences

12/05/2020 14:16

** Shares of medical device and supplement maker  GHSI.O 
jump 6% to 53 cents premarket; among most heavily traded stocks
across U.S. exchanges
    ** Company's liquid formula Lumega-Z helped restore visual
function by providing significantly higher blood concentration
levels of carotenoids- a type of pigmentation  urn:newsml:reuters.com:*:nGNX8LYPw6
    ** The formula was tested in a study in comparison to
current standard of care, AREDS 2 soft gel supplement
    ** GHSI says higher blood concentration levels of
carotenoids helps in slowing the progression of macular
degeneration, an eye disease
    ** Stock more than doubled in value this year, as of
Monday's close

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))